❌

Reading view

SHP1 expression in tumor-associated dendritic cells drives immunoevasion via impairing CD8<sup>+</sup> memory T cell responses

Oncogenesis, Published online: 15 May 2026; doi:10.1038/s41389-026-00627-z

SHP1 expression in tumor-associated dendritic cells drives immunoevasion via impairing CD8+ memory T cell responses
  •  

Towards High-Consistency Embodied World Model with Multi-View Trajectory Videos

arXiv:2511.12882v3 Announce Type: replace-cross Abstract: Embodied world models aim to predict and interact with the physical world through visual observations and actions. However, existing models struggle to accurately translate low-level actions (e.g., joint positions) into precise robotic movements in predicted frames, leading to inconsistencies with real-world physical interactions. To address these limitations, we propose MTV-World, an embodied world model that introduces Multi-view Trajectory-Video control for precise visuomotor prediction. Specifically, instead of directly using low-level actions for control, we employ trajectory videos obtained through camera intrinsic and extrinsic parameters and Cartesian-space transformation as control signals. However, projecting 3D raw actions onto 2D images inevitably causes a loss of spatial information, making a single view insufficient for accurate interaction modeling. To overcome this, we introduce a multi-view framework that compensates for spatial information loss and ensures high-consistency with physical world. MTV-World forecasts future frames based on multi-view trajectory videos as input and conditioning on an initial frame per view. Furthermore, to systematically evaluate both robotic motion precision and object interaction accuracy, we develop an auto-evaluation pipeline leveraging multimodal large models and referring video object segmentation models. To measure spatial consistency, we formulate it as an object location matching problem and adopt the Jaccard Index as the evaluation metric. Extensive experiments demonstrate that MTV-World achieves precise control execution and accurate physical interaction modeling in complex dual-arm scenarios.
  •  

Artificial Intelligence for Predicting Immunotherapy Efficacy in Non-Small Cell Lung Cancer

J Inflamm Res. 2026 Mar 17;19:581764. doi: 10.2147/JIR.S581764. eCollection 2026.

ABSTRACT

Immune checkpoint inhibitors (ICIs) have significantly improved the clinical outcomes for patients with non-small cell lung cancer (NSCLC). However, patient heterogeneity and the limitations of current biomarkers contribute to variations in therapeutic responses. Identifying potential beneficiaries of immunotherapy and predicting efficacy remain critical challenges. In recent years, artificial intelligence (AI) has become increasingly applied in cancer treatment, particularly for modeling clinical data and predicting patient prognosis. By integrating multi-omics data such as radiomics, pathomics, genomics, transcriptomics, proteomics, and microbiomics, AI enables comprehensive biomarker discovery and facilitates prediction of immunotherapy responses and potential toxicities in NSCLC patients. Despite these advancements, challenges such as data standardization, limited interpretability, and technical barriers persist. This review summarizes the application of AI in predicting immunotherapy efficacy for NSCLC patients and discusses the challenges and future directions in the context of precision medicine.

PMID:41867453 | PMC:PMC13005593 | DOI:10.2147/JIR.S581764

  •  
❌